These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24823927)

  • 1. Acute and 14-day hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosis.
    Silkauskaitė V; Kupčinskas J; Pranculis A; Jonaitis L; Petrenkienė V; Kupčinskas L
    Medicina (Kaunas); 2013; 49(11):467-73. PubMed ID: 24823927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
    Kim SG; Kim TY; Sohn JH; Um SH; Seo YS; Baik SK; Kim MY; Jang JY; Jeong SW; Lee B; Kim YS; Suk KT; Kim DJ
    Am J Gastroenterol; 2016 Nov; 111(11):1582-1590. PubMed ID: 27575713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol or propranolol in portal hypertension? A randomized comparison.
    Hobolth L; Møller S; Grønbæk H; Roelsgaard K; Bendtsen F; Feldager Hansen E
    Scand J Gastroenterol; 2012 Apr; 47(4):467-74. PubMed ID: 22401315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics.
    De BK; Das D; Sen S; Biswas PK; Mandal SK; Majumdar D; Maity AK
    J Gastroenterol Hepatol; 2002 Feb; 17(2):183-9. PubMed ID: 11966949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
    Bañares R; Moitinho E; Matilla A; García-Pagán JC; Lampreave JL; Piera C; Abraldes JG; De Diego A; Albillos A; Bosch J
    Hepatology; 2002 Dec; 36(6):1367-73. PubMed ID: 12447861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
    Erdoğan O; Ertem B; Altun A
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension.
    Zepeda RJ; Castillo R; Rodrigo R; Prieto JC; Aramburu I; Brugere S; Galdames K; Noriega V; Miranda HF
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):309-16. PubMed ID: 22703478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients.
    Marazzi G; Volterrani M; Caminiti G; Iaia L; Massaro R; Vitale C; Sposato B; Mercuro G; Rosano G
    J Card Fail; 2011 Sep; 17(9):703-9. PubMed ID: 21872138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of low-dose carvedilol, nebivolol, and metoprolol on central arterial pressure and its determinants: a randomized clinical trial.
    Studinger P; Tabák ÁG; Chen CH; Salvi P; Othmane TE; Torzsa P; Kapocsi J; Fekete BC; Tislér A
    J Clin Hypertens (Greenwich); 2013 Dec; 15(12):910-7. PubMed ID: 24119182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.
    Li T; Ke W; Sun P; Chen X; Belgaumkar A; Huang Y; Xian W; Li J; Zheng Q
    BMJ Open; 2016 May; 6(5):e010902. PubMed ID: 27147389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT.
    Gupta V; Rawat R; Shalimar ; Saraya A
    Hepatol Int; 2017 Mar; 11(2):181-187. PubMed ID: 27624505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
    Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
    Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: Systematic review and meta-analysis.
    Aguilar-Olivos N; Motola-Kuba M; Candia R; Arrese M; Méndez-Sánchez N; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2014; 13(4):420-8. PubMed ID: 24927613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aortic elastic properties : effects of carvedilol versus nebivolol.
    Sayin MR; Aydin M; Dogan SM; Karabag T; Cetiner MA; Aktop Z
    Herz; 2013 May; 38(3):299-305. PubMed ID: 23263241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. After proper optimization of carvedilol dose, do different child classes of liver disease differ in terms of dose tolerance and response on a chronic basis?
    Wani ZA; Baht RA; Bhadoria AS; Maiwall R; Majeed Y; Khan AA; Zargar SA; Shah MA; Khan KM
    Saudi J Gastroenterol; 2015; 21(5):278-83. PubMed ID: 26458853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study.
    Schwarzer R; Kivaranovic D; Paternostro R; Mandorfer M; Reiberger T; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1162-1169. PubMed ID: 29492989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
    Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.
    Forrest EH; Bouchier IA; Hayes PC
    J Hepatol; 1996 Dec; 25(6):909-15. PubMed ID: 9007720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.